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a b s t r a c t
The UL84 gene of human cytomegalovirus (HCMV) is thought to be involved in the initiation of viral DNA
replication, and is essential for replication of strains AD169 and Towne. Hence, discovery that strain
TB40-BAC4 is viable in the absence of UL84 presented an enigma requiring an explanation. Data reported
here show that strain TR also tolerated loss of UL84, whereas strains FIX, Merlin, Ph, and Toledo did not.
UL84-independent growth required the viral replication origin. The genetic locus in TB40 that controls
UL84 dependence was mapped to codon 388 of the UL122 gene, which encodes the immediate early 2
(IE2) 86 kD protein. Introduction of this TB40-BAC4 variant (H388D) into FIX and Toledo clones
converted these strains to UL84 independence. These results provide genetic evidence in virus-
infected cells that supports the hypothesis that UL122 participates in the initiation of viral DNA
replication by a mechanism involving transcription-mediated activation of the origin.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Synthesis of human Herpesvirus DNA requires a conserved set of
six viral replication fork proteins (core) and one or more viral
initiation proteins that are not conserved among the alpha, beta,
and gamma subfamilies. For the beta-herpesvirus human cytome-
galovirus (HCMV), the UL84 gene product was implicated as a
candidate for an initiation protein because it is required for
replication of a plasmid containing a cloned lytic origin of replica-
tion, oriLyt (Anders et al., 1992; Anders and Punturieri, 1991;
Hamzeh et al., 1990), in a transient transfection assay (Pari and
Anders, 1993; Sarisky and Hayward, 1996). UL84 protein associates
with oriLyt in infected cells and virions (Colletti et al., 2007);
however, there is no evidence that UL84 protein binds directly to
DNA. Rather, it is probably recruited to oriLyt by binding to one or
more of the proteins encoded by UL122 (Colletti et al., 2004;
Sanders et al., 2008; Spector and Tevethia, 1994; Xu et al., 2004a)
and/or the polymerase subunit product of the UL44 gene (Gao et al.,
2008; Strang et al., 2009), one of the core replication fork
components.
UL84 is essential for growth of bacterial artiﬁcial chromosome
(BAC) clones of strains AD169 (Xu et al., 2004b; Yu et al., 2003; Gao
et al., 2010; Strang et al., 2012) and Towne (Dunn et al., 2003) in
tissue culture, and in its absence viral DNA synthesis cannot be
detected (Xu et al., 2004b). In contrast, a clone of HCMV strain
TB40E [TB40-BAC4 (Sinzger et al., 2008, 1999)] with a deletion of
the UL84 reading frame is viable (Spector and Yetming, 2010). This
mutant virus replicates with the same kinetics as wild type TB40-
BAC4 and produces about one-third as much viral DNA and
infectious virus (Spector and Yetming, 2010). These observations
prompted investigation both of the replication dependence of
other strains on UL84 and of the genetic variation responsible
for the different behaviors of the different strains.
Results
Evaluation of additional HCMV strains for UL84 dependence
UL84-deletion mutations were produced in BAC clones of ﬁve
different HCMV strains by replacing the 587 codon UL84-reading
frame (He et al., 1992) with a bacterial galactokinase expression
cassette (galK). Strains FIX, Merlin, PH, Toledo, and TR (Murphy
et al., 2003; Stanton et al., 2010) each retain the consensus genome
structure of fresh viral isolates (Prichard et al., 2001). In this
respect, they are similar to the genome of TB40-BAC4, but not to
those of AD169 and Towne, which were derived after extensive
propagation of the viruses in cell cultures, resulting in major
genomic alterations (Cha et al., 1996; Dunn et al., 2003; Murphy
and Shenk, 2008; Murphy et al., 2003).
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Electroporation of galK-containing, UL84-deleted versions of
FIXGFPBAC, MerlinBAC, PhBAC, and ToledoBAC into MRC5 cells did
not yield any virus. However the corresponding mutant derived
from TRGFPBAC (TRGFPBACΔ84galK) generated numerous foci of
infected cells, and the UL84 region of viral DNA isolated from the
infected cultures had the sequence content expected for a galK
replacement of UL84 with no evidence of the wild type UL84 gene
(Fig. 1A). The replication kinetics of TRGFPBACΔ84galK were
similar to that of TRGFPBAC (Fig. 1B), although the virus yields
were about a half-log lower. TRGFPBACΔ84galK-infected cells
did not make any detectable UL84 proteins (Fig. 2A and B). These
properties were indistinguishable from those reported for
TB40GFPBACgalKΔ84 (Spector and Yetming, 2010). Hence, it was
quite clear that TRBAC, like TB40-BAC4, is UL84-independent for
growth.
To prove that the UL84 deletions, rather than other genetic
changes, were responsible for the non-viability of the other four
strains, these mutants were repaired with UL84 derived from
TB40-BAC4. A three-step recombineering protocol [(Zhao et al.,
2011); see Materials and methods for details] was employed after
numerous attempts to revert the mutations directly with a UL84-
containing DNA fragment were unsuccessful (data not shown). In
the ﬁrst step, galK was removed leaving a UL84 deletion. Then a
copy of the UL84 gene of TB40-BAC4 with a galK insertion was
introduced. Finally, galK was removed again in a way that restored
the intact TB40-BAC4 UL84 sequence. Each of the repaired BACs
was viable (data not shown, but summarized in Table 1). That they
were derived from a repair event was veriﬁed by examining the
sequence of the UL84 genes; all were TB40-BAC4 (data not
shown).
Identiﬁcation of the genetic locus controlling UL84 independence
Two possible mechanisms for UL84 independence were
explored. The ﬁrst was that independent strains contain an
undiscovered origin of replication that does not require UL84 for
its function. If so, then replication of TB40-BAC4-derived viruses
would also be independent of oriLyt. To test this hypothesis, a
1.5 kb segment of oriLyt in TB40mChBAC or TB40mChBACΔ84
(Spector and Yetming, 2010) was replaced with galK to produce
TB40mChBACΔorigalK and TB40mChBACΔ84ΔorigalK, respec-
tively. This region of oriLyt is required for AD169 origin function
(Borst and Messerle, 2005). Neither strain with an oriLyt deletion
and galK insertion was viable, and replication was rescued by
restoring the wild type oriLyt sequence (data not shown). Thus, it
appeared that oriLyt is required for replication of TB40-BAC4-
derived viruses.
The second possible mechanism of UL84 independence was
variation in a viral gene product that enables it to promote viral
DNA replication in place of, or at least in the absence of, UL84.
Initially, the known nucleotide sequences of the eight strains listed
in Table 1 were inspected, but too many differences were found to
identify ones that co-segregate with the phenotypes of the ΔUL84
strains. Survey of ninety-one different orfs, including all of those
with demonstrated or suspected nuclear localization (Salsman
et al., 2008), was similarly unproductive. Accordingly, different
strategies were explored for producing recombinants of UL84-
dependent and -independent strains that would map the critical
locus, if there were only a single one.
A marker rescue approach was successful. For this experiment,
the BAC containing UL84-dependent strain MerlinΔ84 was elec-
troporated into MRC5 cells along with TRGFPBAC DNA fragments
generated by digestion with KpnI (see Materials and methods).
Some viable recombinants produced fast-spreading CPE, and these
were predicted to arise by direct repair of the UL84 deletion in the
Merlin strain with the wild-type gene from TR. However, other
viable recombinants were obtained that exhibited slower-
spreading CPE, consistent with the predicted phenotype of a
MerlinBACΔ84 genome that had acquired the TR region that
confers UL84-independence. Twenty virus clones were isolated
by limiting dilution, and viral DNA was prepared from each. The
UL84 status of each genome was determined by PCR analysis.
Seventeen of the clones had UL84 sequences restored whereas
three, designated MerlinΔ84recTR-1, 2 and 3, had the same UL84
deletion as MerlinBACΔ84.
The three recombinants were sequenced, and the genomic
regions derived from Merlin or TR DNA were analyzed by compar-
ing the sequence of the recombinants with the published
sequences of MerlinBAC and TRBAC (Dolan et al., 2004; Murphy
et al., 2003; Stanton et al., 2010). The genome sequences were
from Merlin except for a region of TR sequence from the largest
KpnI DNA fragment. The TR DNA regions in clones 2 and 3 were
larger and indistinguishable from each other so they were likely to
have been sister clones (data not shown). The TR DNA in clone
1 was a 4.5-kbp sub-region of the TR DNA in the other two clones,
and it extended from within UL117 to within UL122 (Fig. 3A). This
TR DNA segment in the MerlinΔ84recTR-2 genome seemed likely
to be the source of the rescued viability of the MerlinΔ84
genomes; however, this interpretation was uncertain because the
virus stock that was ampliﬁed and used to generate DNA for
Fig. 1. Structure and replication of TRGFPBACΔ84galK. (A) PCR analysis of viral
DNA. DNA was prepared from TRGFP (wt) or TRGFPΔ84galK (Δ84) virus stocks for
ampliﬁcation as described in Materials and methods. The positions of UL84-region
primer pairs (numbers correspond to primers listed in Table 2) are indicated along
with the sizes of the expected ampliﬁcation products from each genome. M: 1 kbþ
(New England Biolabs, Inc.) DNA length standards. Lanes 1: No DNA; lanes 2:
primer pair 164/165; lanes 3: primer pair 109/91; lanes 4: primer pair 164/21. The
arrow in lane 2 of the “wt” panel indicates the expected product; the other
products in this lane are PCR artefacts. (B) Replication kinetics of TRGPPΔ84galK.
MRC5 cells were infected at a MOI of 0.01 and virus titers were determined by
plaque assay of samples collected at the times indicated after infection. The zero
time represents the input virus amount. The results shown are from one of two
duplicate experiments.
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sequencing had not been plaque puriﬁed, and there was evidence
that it was contaminated with recombinant Merlin virus contain-
ing a TR UL84 gene (see Materials and methods).
To seek deﬁnitive evidence that the TR DNA segment from the
UL117-UL122 region could restore viability to dependent strains
that lack UL84 and to map the contributing genetic locus more
precisely, additional genetic analyses were performed. UL117 could
be ruled out because its predicted amino acid sequences in TB40-
BAC4, an independent strain, and MerlinBAC, a dependent strain,
are identical. Moreover, the UL118–121 region was unlikely to
provide the source of UL84-independence, because individually or
in some combinations, UL118 (also designated UL119 exon 2),
UL119 (exon 1), UL120, and UL121, are non-essential for growth of
HCMV AD169 or Towne (Atalay et al., 2002; Dunn et al., 2003; Yu
et al., 2003). However, a complete deletion of the UL118–121
region had not been tested. Accordingly, this region was replaced
with galK in a UL84-dependent strain (Merlin BAC) and in both
UL84-independent strains (TB40mChBACΔ84 and TRGFPBACΔ84,
Fig. 3B). All of the clones with galK replacements of UL118–121
produced virus (data not shown). Therefore, the locus controlling
UL84 dependence did not map in this region, and further attention
was directed to UL122.
UL122 alleles that confer UL84 independence
UL122 gene sequences are expressed as a complex series of
protein products from a variety of spliced mRNAs (Fig. 4A).
Inspection of all the UL122-coding sequences of the eight strains
listed in Table 1 did not reveal any single locus where variation in
the amino acid sequence co-segregated with the UL84 dependence
phenotypes. However, alignments based on the IE2 86 kDa protein
(Fig. 4B), which contains 579 aa in strain AD169 (Chee et al., 1990;
Hermiston et al., 1987; Malone, Vesole, and Stinski, 1990; Stenberg
et al., 1989; Stenberg and Stinski, 1985; Stinski et al., 1983),
revealed that the TB40-BAC4 genome encodes an aspartic acid
(D) at position 388, whereas all of the other strains encode a
histidine (H) (Chee et al., 1990; Murphy et al., 2003; Stanton et al.,
2010). Similarly, TRBAC encodes a D at position 545 whereas all of
the other strains specify an alanine (A). These changes became
candidates for genetic variations that render the two strains UL84-
independent.
Two different approaches were used to test whether the H388D
variation would convert UL84-dependent strains to UL84 inde-
pendence. The ﬁrst was a marker rescue strategy in MRC5 cells.
Cells were co-electroporated with DNA from a dependent strain
that lacks UL84 and an oligonucleotide derived from the TB40-
BAC4 UL122 sequence, which contains the single base-pair change
that creates the D388 codon. A focus of viral growth was observed
in a culture that received ToledoBACΔ84 DNA, and the virus was
designated ToledoΔ84H388D. Viral DNA was prepared and the
UL84 and UL122 regions of the genome were assessed by PCR and
restriction enzyme digestion. ToledoΔ84H388D still had the UL84
deletion of the ToledoBACΔ84 clone from which it was derived
(Fig. 5A). To look for the predicted change in codon 388, a 726 bp
PCR product from this region of UL122 was digested with AvaII
because the base change that converted codon 388 from H-coding
Fig. 2. UL84 protein synthesis in TRGFPΔ84galK-infected cells. MRC5 cells were infected with TRGFP (wt) or TRGFPΔ84galK (Δ84) virus at a MOI of 0.5, or mock-infected (–),
for 48 h. (A) Infected cells on cover slips were processed for immunoﬂuorescence with antibody 9G3 (UL84) or 3A9 (IE1). Mock-infected cells produced background levels of
ﬂuorescence with either antibody (not shown). Background ﬂuorescence in these images may have been produced, at least in part, by spillover of GFP into the red channel
used to detect the cy3 ﬂuor. (B) Infected cells in dishes were harvested and protein extracts were prepared. Immunoblotting was performed with 9G3, 3A9, or anti-tubulin
antibodies.
Table 1
Growth phenotypes of cloned HCMV strains.
Strain ΔUL84 UL84 repair References
AD169BAC Non-viable Viable (Xu et al., 2004b; Yu, Silva, and Shenk, 2003)
FIXGFPBAC Non-viable Viable This work
MerlinBAC Non-viable Viable This work
PhBAC Non-viable Viable This work
TB40-BAC4 Viable NA (Spector and Yetming, 2010)
ToledoBAC Non-viable Viable This work
TowneBAC Non-viable ND (Dunn et al., 2003)
TRGFPBAC Viable NA This work
NA: not applicable.
ND: not evaluated.
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to D-coding also introduced a site for this enzyme. Thus, a genome
with the D-coding sequence should have an additional AvaII site
replacing the 316-bp product of the parental Toledo strain (H388)
with 206- and 110-bp products. Moreover, BstN1digestion of
Toledo-derived DNA adjacent to the 200 bp fragment used for
the marker rescue should produce 420- and 198-bp products,
rather than a 618-bp product that would be observed if somehow
more extensive TB40-BAC4-derived DNA had been incorporated
into the recombinant genome. The observed restriction patterns
(Fig. 5B) were precisely those predicted for ToledoΔ84H388D.
In a second approach for testing the importance of H388D, this
codon change was introduced into the UL84-dependent FIXGFP-
BACΔ84 strain to ascertain whether it would become indepen-
dent. Three different BAC clones that retained the UL84 deletion
were tested for their viability. Numerous foci of CPE were obtained
for each clone; their rate of expansion was consistent with that
observed previously for UL84-independent strains, with many foci
containing ﬁfty to a hundred GFP-positive cells by 17d after
electroporation (data not shown). DNA isolated from the resulting
virus stocks generated PCR products (Fig. 6A, lanes 3–5) of the
sizes expected for genomes that maintained the UL84 deletion
(Fig. 6A, lanes 2), as opposed to those with wt UL84 (Fig. 6A, lanes
1). Moreover, the UL122 genes of the three clones (Fig. 6B, lanes 3–
5) contained the new AvaII site introduced by the H388D codon
change but maintained the FspI and RsaI sites expected of the FIX
UL122 gene (Fig. 6B, lanes 1) rather than that of TB40-BAC4
(Fig. 6B, lanes 2). The isolation of these viable Toledo and FIX
Δ84 variants shows that the H388D conversion in UL122 was
sufﬁcient to confer UL84 independence to UL84-dependent HCMV
strains.
Discussion
Genetic and molecular evidence have implicated the UL84 gene
of HCMV as being essential for the initiation of viral DNA replica-
tion. Hence, the discovery that strain TB40-BAC4 replicates without
the need for UL84 (Spector and Yetming, 2010) raised questions
about the actual role of this protein and provided a potential
opportunity to genetically probe the mechanism of initiation in
infected cells. Data presented here shows that the UL84-
independent growth phenotype is shared by at least one other
strain, TRGFPBAC, and that this property is conferred by genetic
variation in UL122. Introduction of the UL122 388D variant from
TB40-BAC4 into UL84-dependent strains Toledo and FIX converted
both to UL84 independence. There is a good circumstantial case that
the TR 545D variant also has the same capacity. First, the genetic
analysis showed that the portion of the TR genome that is required
for replication in the absence of UL84 maps to UL122 or the UL121–
122 intergenic region (Fig. 3), and A545D is the only difference in
that region that co-segregates with independence. Second, the
amino acids ﬂanking residue 545 are conserved among primate
and rodent cytomegaloviruses (Fig. 4B); and in the UL122 homolog
of guinea pig cytomegalovirus, which is also UL84-independent for
growth (McGregor et al., 2011), an acidic residue (E rather than D)
replaces the highly conserved alanine (Schleiss et al., 2008).
The mechanism underlying UL84-independence is yet to be
determined. UL122 is an essential gene (Heider et al., 2002;
Marchini et al., 2001; White et al., 2004), which is implicated in
a wide variety of regulatory functions including viral and cell gene
activation and repression (Bresnahan et al., 1998; Caswell et al.,
1993; Cherrington et al., 1991; Hagemeier et al., 1992; Hermiston
et al., 1990; Hermiston et al., 1987; Jupp et al., 1993; Liu et al., 1991;
Fig. 3. Recombinant region of MerlinΔ84recTR-1. (A) The segment shown extends
from Merlin nucleotide positions 166,796 to 173,796 with tick marks every 1 kbp.
The delimited line indicates the segment of Merlin DNA that was replaced by TR
DNA in the recombinant. The boundaries are approximate based on the nearest
single nucleotide polymorphisms. (B) Structure of Δ118–121galK BAC clones. The
galK cassette (dark arrow) replaced the region of the BAC delimited by the start
codon of UL121 and the stop codon of UL118.
Fig. 4. UL122 region of HCMV. (A) UL122 mRNAs and proteins. The exon structure
of UL122-containing mRNAs (boxes and arrows) is indicated along with the
designations of the translation products and the initiation and termination codons
that produce them. The dashed lines indicate the position of codons 388 and 545.
(B) Encoded amino acid sequences in cytomegalovirus UL122 genes for conserved
regions adjacent to histidine 388 and alanine 545 [AD169 IE2 86 amino acid
designations (Chee et al., 1990)]. Positions 388 and 545 are shaded and the
replacement of conserved residues by acidic residues is indicated by underline
and bold. The single amino acid code is used. TB: TB40-BAC4 (Sinzger et al., 2008);
TR: TRBAC (Murphy et al., 2003); FIX: FIXBAC (Murphy et al., 2003); Me: MerlinBAC
(Dolan et al., 2004; Stanton et al., 2010); Ph: PhBAC (Murphy et al., 2003); Tol:
ToledoBAC (Murphy et al., 2003); AD: AD169BAC (Chee et al., 1990; Murphy et al.,
2003); Tow: TowneBAC (Murphy et al., 2003); chCMV: chimpanzee cytomegalo-
virus (Davison et al., 2003); rhCMV: rhesus cytomegalovirus (Hansen et al., 2003);
gpCMV: guinea pig cytomegalovirus (Schleiss et al., 2008); mCMV: mouse
cytomegalovirus (Rawlinson et al., 1996); rCMV: rat cytomegalovirus (Vink et al.,
2000).
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Malone et al., 1990; Pizzorno and Hayward, 1990; Pizzorno et al.,
1988; Song and Stinski, 2002; Tevethia et al., 1987), cell cycle
progression (Bresnahan et al., 1996; Murphy et al., 2000; Sinclair
et al., 2000; Sommer et al., 1994; Weibusch and Hagemeier, 1999),
apoptosis (Zhu et al., 1995), disruption of ND10 nuclear structures
(Ahn and Hayward, 1997; Ishov et al., 1997), and inhibition of
cellular DNA synthesis (Bresnahan et al., 1996; Song and Stinski,
2005). Among the overlapping proteins expressed from UL122
(Fig. 4A), most studies have focused on the 86 kD immediate early
(IE) protein, designated IE86 or IE2 86, which contains two amino-
terminal segments encoded by exons shared with the major product
of the UL123 gene (Hermiston et al., 1987; Pizzorno et al., 1991;
Stenberg et al., 1989; Stinski et al., 1983). At least two other proteins,
60 kD (IE2 60) and 40 kD (IE2 40), are encoded exclusively by UL122
and accumulate later in infection (Plachter et al., 1993; Puchtler and
Stamminger, 1991). Selective genetic ablation of their synthesis results
in a severe growth defect (White et al., 2007), and they, too, have
gene regulatory activities (Jenkins et al., 1994; Sanders et al., 2008;
Sanders and Spector, 2010; White et al., 2007). Like the 86 kD product
(Spector and Tevethia, 1994; Gebert et al., 1997), the 60 and
40 kD products can interact individually with the UL84 protein
(Sanders et al., 2008), and IE2 40 in particular enhances the expres-
sion of UL84 (Sanders et al., 2008; Sanders and Spector, 2010;
White et al., 2007). All three of these UL122 products contain the
H/D388 and A/D545 residues. Little is known about the functions
of two additional UL122-encoded proteins, IE2 18 and IE2 55
(Kerry et al., 1995; Stenberg et al., 1989). These proteins contain the
segment including amino acid 545 but not amino acid 388. Viruses
expressing subsets of UL122 products should help identify the species
whose variants are capable of conferring UL84 independence.
Regardless of which UL122 product(s) is responsible, it is
probable that the gain-of-function phenotype of the variants
(i.e., the ability to grow without UL84) arises from a quantitative
change in one or more activities of the protein, rather than
acquisition of a new function. As suggested by previous studies
in transfected cells (Pari and Anders, 1993; Reid et al., 2003;
Sarisky and Hayward, 1996; Xu et al., 2004a), it seems most likely
that the substitutions enhance the ability of UL122 to participate
in the initiation of viral DNA replication. How might this work?
Over 20 years ago, it was shown that elimination of various acidic
residues in the 550–573 region reduces the ability of IE2 to
transactivate early gene promoters (Yeung et al., 1993); hence, it
is reasonable to predict that the acquisition of an additional acidic
residue at position 388, or at position 545, increases transactiva-
tion of a promoter by IE2. This is a particularly attractive hypoth-
esis because the mechanism of unwinding during the initiation of
DNA synthesis for HCMV has been proposed to be a transcription-
ally driven process [see (Pari, 2008)], similar to that proposed for
the initiation of mitochondrial DNA replication (Lee and Clayton,
1996; Xu and Clayton, 1995; Xu and Clayton, 1996). The promoter
region for the nearby UL57 gene activates oriLyt (Kiehl et al.,
2003), and a region of oriLyt itself (oriLytPM) that contains a
functional IE2 binding site also has promoter activity (Xu et al.,
2004a). Moreover, when the SV40 early promoter replaces ori-
LytPM, the resulting replicon still functions in a transient replica-
tion assay, and replication is rendered independent of IE2 (Xu
et al., 2004a). Also, several RNA species (vRNA) are made from
oriLyt and captured in RNA-DNA hybrid structures at the origin
Fig. 5. Restriction endonuclease site analysis of UL84 and UL122 alleles in
ToledoΔ84 virus strains. Viral DNA was extracted from ToledoΔ84H388D, Toledo,
or TRGFPΔ84 virus preparations as described in Materials and Methods. (A) Each
sample was ampliﬁed with the UL84 primer pairs indicated (see Table 2). The
products expected for the wt UL84 or Δ84 alleles are shown on the right. Lanes 1:
ToledoΔ84H388D; lanes 2: Toledo; lanes 3: TRGFPΔ84; lanes 4: no template. M:
1 kbþ DNA length standards. (B) A 726-bp region of UL122 was ampliﬁed by PCR
using the primer pair 196/189 (see Table 2). The PCR product was digested with the
restriction endonuclease indicated. The left panel shows the banding pattern from
each sample. M: 1 kbþ DNA length standards. The right panel shows the products
expected from each UL122 allele. Tol: Toledo allele; TB: TB40-BAC4 allele. The thick
part of the line indicates the position of the 198-bp PCR product derived from
TB40-BAC4 and used to produce ToledoΔ84H388D.
Fig. 6. Analysis of genomes from single amino acid change variants of FIXGFPΔ84 that
conferred UL84 independence. (A) Viral DNA samples were ampliﬁed with the UL84
region primer pairs indicated. Lanes 1: TB40mCh; lanes 2: TB40mChΔ84; lanes 3:
FIXGFPΔ84H388Dcl1; lanes 4: FIXGFPΔ84H388Dcl2; lanes 5: FIXGFPΔ84H388Dcl3;
lanes 6: no DNA. M: 1 kbþ DNA length standards. (B) Viral DNA samples were
ampliﬁed with the UL122 primer pair 196/189 (Table 2) and digested with the
restriction endonucleases indicated. Lanes 1: FIXGFP; lanes 2: TB40mCh; lanes 3:
FIXGFPΔ84H388Dcl1; lanes 4: FIXGFPΔ84H388Dcl2; lanes 5: FIXGFPΔ84H388Dcl3; M:
1 kbþ DNA length standards
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(Prichard et al., 1998). UL84 and UL122 synergistically activate
oriLytPM (Xu et al., 2004a). Thus, it will be of interest to ascertain
whether the variants reported here are capable of increasing
activation of oriLytPM by UL122 alone to an extent sufﬁcient to
relieve the requirement for UL84.
The ﬁndings of this study have implications for other UL84
activities that have been attributed to origin function. For example,
it has been suggested that UL84 protein binds to one or more vRNA
species or RNA-DNA hybrids in oriLyt (Colletti et al., 2007), and that
UL84 modiﬁes the nucleic acid structure, perhaps through a helicase
activity (Colletti et al., 2006, 2007). Clearly, these activities must not
be essential for the initiation of DNA replication because single
amino acid substitutions in UL122 can eliminate the need for UL84.
In summary, the results presented here provide genetic evi-
dence in infected cells for a direct role of UL122 in oriLyt function.
It remains to be seen whether the two novel alleles that have been
identiﬁed are widespread in nature or whether other changes also
can enable UL84 independence. Whether these or other substitu-
tions in UL122 also provide a selective advantage to UL84-
containing strains remains to be determined.
Materials and methods
Cells and viruses
MRC5 cells were maintained as described previously (Spector
and Yetming, 2010) in Dulbecco's modiﬁed Eagle's medium (DMEM,
Invitrogen) supplemented with 2 mM glutamine, 100 U of penicillin
per ml, 100 U of streptomycin per ml, 0.15% sodium bicarbonate and
10% fetal bovine serum (Hyclone Laboratories, Inc.).
BAC clones of the HCMV genomes AD169, and TB40mCherry
were described previously (Spector and Yetming, 2010). FIXGFP,
Ph, Toledo, Towne and TRGFP genomes (Murphy et al., 2003) were
provided by Eain Murphy and Tom Shenk as BAC clones in E. coli
SW105 (Warming et al., 2005). Expression of the color markers is
mediated by an SV40 origin/promoter in a cassette inserted
between the US34 and TRS1 genes (E. Murphy, personal commu-
nication). Richard Stanton provided pAL1111, a clone of the Merlin
genome (Stanton et al., 2010) referred to here as MerlinBAC.
Virus stocks were prepared from MRC5 cells electroporated
with BAC DNA from an infectious clone as described previously
(Spector and Yetming, 2010).
BAC mutagenesis
BAC sequences were manipulated by recombineering using
galK as the selectable marker in strains SW102 or SW105 as
described previously (Spector and Yetming, 2010). Table 2 lists
the primers and oligonucleotides that were used in these experi-
ments. In some cases the homologous recombination activity of
BAC-containing strains was lost. When that occurred, BAC DNA
was isolated and transferred to a new SW102 or SW105 host for
further mutagenesis.
The construction of TB40GFPBACgalKΔ84, a clone of TB40-
BAC4 with a GFP expression unit and a galK replacement of the
smaller UL84 reading frame, was described previously (Spector
and Yetming, 2010). An identical strategy using primers 87 and 88
and selection for galK was used to produce galK replacements of
the corresponding UL84 gene sequences in FIXGFPBAC, PhBAC,
ToledoBAC, TRGFPBAC, and MerlinBAC.
The galK cassette was excised by counter-selection to produce
Δ84 BACs essentially as described by Warming et al. (2005).
Electro-competent cells were prepared as for the galK insertion
and electroporated with a double-stranded DNA generated by
incubating 10 mg each of oligonucleotides 158 and 159 (Table 2) in
0.1 ml of 1X Standard Taq Buffer (New England BioLabs, Inc.) for
5 min at 100 1C and keeping at room temperature for 30 min. The
double-stranded DNA was precipitated with sodium acetate and
ethanol, collected by centrifugation and suspended in water at a
ﬁnal concentration of 200 mg/ml. 0.5 mg was used for each electro-
poration. After electroporation in conditions described previously
(Spector and Yetming, 2010) 0.05 ml of transformed cells were
diluted to 10 ml with YENB (7.5 g/L yeast extract; 8.0 g/L nutrient
broth) and kept at 321 for 4.5 h in a shaking incubator. One ml of
cells was collected and washed three times with 1 ml of M9
medium (6 g/L Na2HPO4, 3 g/L KH2PO4, 1 g/L NH4CL, 0.5 g/L NaCl),
suspended in 1 ml of M9, and 0.1 ml was plated on M63 medium
(2 g/l (NH4)2SO4, 13.6 g/L KH2PO4, 0.5 mg/L FeSO4 7H2O, pH 7.0)
containing 0.2% 2-deoxy-galactose, 0.2% glycerol, 0.01% leucine,
1 mg/ml biotin, 0.5 mM MgSO4 7H2O and 12.5 mg/ml chloramphe-
nicol. Colonies were picked and plated on YENB containing
12.5 mg/ml chloramphenicol, or M63 plates with the additions
indicated above except that the carbon source was 0.2% galactose,
and the glycerol and 2-deoxy-galactose were omitted. Colonies
that grew only on the YENB plates were grown in liquid culture
and the BAC DNA was isolated as described above. The loss of galK
and maintained absence of the UL84 reading frame were con-
ﬁrmed by PCR and DNA sequencing of the PCR products.
To restore wild type UL84 sequences in Δ84 BACs a region of
the TB40GFPBACUL84galKm7 genome, which has a galK replace-
ment of a short segment of UL84, was introduced into the Δ84
BACs by galK selection. TB40GFPBACUL84galKm7 was constructed
from TB40GFPBAC using primers 142 and 143. The UL84 gene
region of TB40GFPBACUL84galKm7, including about 400 bp of
genomic sequences at either end of the reading frame, was
ampliﬁed with primers 164 and 165. Standard electroporation
reactions containing 0.75 mg of this DNA fragment and a Δ84 BAC
were plated, and galK-containing clones were isolated. After
identifying UL84galKm7 BACs by PCR, the wild type TB40-BAC4
UL84 sequence was restored by counter-selection after recombi-
neering with 1 mg of a double-stranded DNA fragment produced
by the annealing of oligonucleotides 178 and 179. Veriﬁcation that
the wild type TB40-BAC4 UL84 sequence repaired the original FIX,
Ph, Merlin, or Toledo Δ84 genomes was performed by using
primer 132 to prime sequencing of a PCR product generated with
primers 109 and 91.
Replacement of 1.5 kbp of oriLyt in TB40mChBAC with galK was
performed by recombineering using primers 151 and 152 to produce
TB40mChBACgalKΔoriLyt. The galK cassette was replaced and the
wild type oriLyt restored by counter-selection using a PCR product
generated with primers 147 and 180, which ampliﬁed the deleted
1.5 kbp region with extensions of about 160 bp on either side.
Replacement of UL118 to UL121 by galK was performed by
recombineering using a DNA product ampliﬁed with primers 185
and 186.
Nucleotide 172,262 in the UL22 gene of FIXGFPBACΔ84 was
mutated from G to C (205,110 in the TB40-BAC4 sequence), to
change codon 388 from specifying histidine to specifying aspartic
acid (H388D). In the ﬁrst step, nt 172,262 was replaced by galK using
a PCR product generated with primers 194 and 195. In the second
step, a synthetic double-stranded TB40-BAC4-derived DNA contain-
ing C at a position corresponding to 205,110 (GB1, IDT corp) was
used in a counter-selection recombineering to replace galK of the FIX
clone with the changed base pair. The FIX and TB40-BAC4 sequences
in this region of UL122 are identical except for the single base pair
difference. Recombinants were designated FIXGFPΔ84H388D.
Recombinant viruses
To produce recombinant viruses between the non-viable BAC
clone of MerlinΔ84 and TRBAC DNA, the latter was digested with
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KpnI and the DNA was puriﬁed with an Illustra GFX PCR DNA and
Gel Band Puriﬁcation Kit (GE Healthcare). The DNAwas concentrated
to about 1 mg/ml and 10 ml of DNA were added to a standard
electroporation reaction containing MerlinΔ84BAC DNA and 1 mg
of pp71-expressing plasmid (Murphy et al., 2008; Spector and
Yetming, 2010). After about two weeks, two different sizes of foci
with virus-infected cells were observed. After one more week, the
cells and virus were harvested, dispersed by soniﬁcation, serially
diluted, and dilutions from 1:10,000 to 1:1,000,000 were distributed
to MRC5 cells growing in separate wells of 12-well plates. Again both
fast-expanding and slow-expanding foci were observed. From two to
three weeks after these infections, contents from twenty wells with
only a single visible focus of virus growth (but see below) were
transferred to MRC5 cells growing in T25 ﬂasks. Five to eight days
after infection of the T25 ﬂasks, the cells and medium from each
were collected separately and stored at 801.
DNAs was isolated from the “cells” sample of each clone using
the QIAamp Mini DNA Kit (Qiagen) and evaluated by PCR for the
status of the UL84 gene. Three of the twenty clones (1, 14, and 17)
had the same UL84 gene deletion as the parent MerlinΔ84BAC and
were designated MerlinΔ84recTR-1, 2 and 3. The virus from these
recombinants was ampliﬁed by transferring a portion of the
medium from the original T25 ﬂask to MRC5 cells growing in a
T175 ﬂask. One-tenth of the virus yield from the T175 ﬂask was
then added to 615-cm dishes of MRC5 cells. After 6 to 7 days,
the cells and medium were pooled and the cells were collected by
centrifugation. The pellet was combined with 5 ml of medium and
disrupted by soniﬁcation in a cup sonicator (Misonix sonicator
3000). Debris was removed by centrifugation and the supernatant
was combined with the remaining medium. The suspension
was layered over 5 ml of 20% sorbitol in 0.05 M Tris–HCl, pH 7.4,
and particulate material including virus was collected by
Table 2
List of Synthetic DNAs.
DNA source No. Sequence Nos. Sequence
PCR primers
galKa 21 453-482 CGCACAAATCGCGCTTAACGGTCAGGAAGC
TB40-BAC4
UL84 region 91 157648-157668c GAATCCTCGTTAGAGACCACG
109 156448-156469 AGTGTCCGTTTTCCATCACCAG
132 156667-156690 GAGTGTAGCGTGGATTTGACTTGG
164 156037-156056 CCAGGATCAGCGAGGGCTGG
165 158605-158624c CAGGTGCTGGTCGATGACCG
UL122 189 205704-205723c TACCATCCAGTACCGCAACA
196 204998-205018 ACCGCATCCACCTCACTCTTC
197 205175-205195c CGGCTCACCTCGTCAATCTTG
oriLyt 147 129085-129103c CCTTATCCTGGGCGTTGGC
180 127270-127290 GGGAGTGTCTACAGGGCTACG
FIXBAC (UL84) 97 124628-124648 TCAACAGCGGCGTGATGATAC
Primers for ampliﬁcation of galK cassette with ﬂanking HCMV DNA sequencesb
TB40-BAC4
UL84 region 87 158232-158281 galK forward GCTTGGTGTCTGCGGGCGCGAGAGGGCCGGCTCAGCCTTTAAATATGCAGCCTGTTGACAATTAATCATCGGCA
142 157167-157216c galK forward GTCCGGCGGTGATTCGTTCGGGTCTAGCTCCAATCGTCCAAAGACGGAGGCCTGTTGACAATTAATCATCGGCA
143 157115-157164 galK reverse CGTTGAAACGTAACATGCCGTCTTGGTATAGCGTGAGTGACGACAGCGTCTCAGCACTGTCCTGCTCCTT
oriLyt 151 127385-127434 galK forward ACGTCACACTCGCGTGACCACACCCACTCCGGATATACGTCATCCCGTGGCCTGTTGACAATTAATCATCGGCA
152 128936-128985 galK reverse GGAGCCGCCGCGAGACCCGGAAGCCGTCGCGGTCGACCCCGCTCCCGAAGTCAGCACTGTCCTGCTCCTT
UL122 194 205060-205109 galK forward GTTCACCTGCATGGTTTTGCAAGCTTTGATGGCCTCATCTAACACCTGGTCCTGTTGACAATTAATCATCGGCA
195 205111-205160c galK reverse CCAATCGCTCTCTTGAGTACAAGAACCTGCCCTTCACGATTCCCAGTATGTCAGCACTGTCCTGCTCCTT
FIXBAC
UL84 region 88 123544-123593 galK reverse CGTATGGCGCGGACGCCTAGTGTCCGTTTCCCATTATCAGGGTCCTCTGTTCAGCACTGTCCTGCTCCTT
Merlin BAC
UL118-121 185 168024-168073 galK forward CGTGTGGAGCCGTAGACGATCTGGACGTGGTCCTGGGAGAACATGACCATCCTGTTGACAATTAATCATCGGCA
186 170565-171614c galK reverse GCTGTTTAATAAAAGTAGCTTTTTTATACATCTCCGTCTCTGGTCTCCTGTCAGCACTGTCCTGCTCCTT
Oligonucleoties
TB40-BAC4
UL84 158 156430-156479, 158232-158281 CGTATTGCGCGGACGCCTAGTGTCCGTTTTCCATCACCAGGGTCCTCTGTCTGCATATTTAAAGGCTGAGCCGGC-
CCTCTCGCGCCCGCAGACACCAAGC
159 158232-158281c, 156430-156479c CGTATTGCGCGGACGCCTAGTGTCCGTTTTCCATCACCAGGGTCCTCTGTACAGAGGACCCTGGTGATGGAAAA-
CGGACACTAGGCGTCCGCGCAATACG
178 157115-157216c CCTCCGTCTTTGGACGATTGGAGCTAGACCCGAACGAATCACCGCCGGACCTGACGCTGTCGTCACTCACGCTAT-
ACCAAGACGGCATGTTACGTTTCAACG
179 157115-157216 CGTTGAAACGTAACATGCCGTCTTGGTATAGCGTGAGTGACGACAGCGTCAGGTCCGGCGGTGATTCGTTCGGG-
TCTAGCTCCAATCGTCCAAAGACGGAGG
UL122 GB1c 205011-205210 CACTCTTCACCTCATGATTGCGGGTGTAGATGATCTGGATGCCCTTGTTGTTCACCTGCATGGTTTTGCAAGCTTT-
GATGGCCTCATCTAACACCTGGTCCATACTGGGAATCGTGAAGGGCAGGTTCTTGTACTCAAGAGAGCGATTGG-
TGTTGCGGAACATGCGGCTCACCTCGTCAATCTTGACGCGACCCCGCCGA
a galK orf of pgalK (Warming et al., 2005).
b sequences from galK cassette in pgalK are in italics.
c double-stranded, only one strand is shown.
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centrifugation at 68,000 x g for 90 min at room temperature in an
SW32 rotor. The supernatant was removed and the pellet was
suspended in 0.05 M Tris–HCl, pH 8.1, 0.01 M EDTA, 0.15 M NaCl
(TSE), and kept at 4 1C until DNA extraction. A control sample was
prepared similarly from cells infected with HCMV Merlin.
To produce a recombinant virus with a G to C mutation in
UL122 that changed codon 388 from histidine- to aspartic acid-
coding, a 198 bp region of UL122 was ampliﬁed with primers 196
and 197. The DNA was electroporated along with FIXGFPBACΔ84,
PhBACΔ84, or ToledoBACΔ84 DNA, and pp71 plasmid directly
into MRC5 cells. A single focus of virus spreading was observed in
the ﬂask that received Toledo DNA. A lysate stock was prepared
from the ﬂask 22 days after the transformation and designated
ToledoΔ84H388D.
DNA isolation
Partially puriﬁed BAC DNA was isolated from 10 ml of bacterial
cultures grown for 16–18 h by a modiﬁed cosmid isolation proce-
dure described previously (Spector and Yetming, 2010). Half of the
sample was used in standard electroporation reactions for virus
production. Highly puriﬁed BAC DNA was isolated from 100 ml of
bacterial cell cultures using the Genopure Plasmid Maxi Kit (Roche
Life Sciences) according to the instructions for low copy number
plasmid isolations provided by the manufacturer.
Viral DNAwas prepared from 0.2 ml of infected cell lysate using
the QIAamp DNA Mini Kit (Qiagen) according to instructions
provided by the manufacturer. To prepare viral DNA from sorbitol
cushion-isolated virus, the suspension was adjusted to 5 mg/ml
N-lauroyl-sarcosine and 100 mg/ml proteinase K and mixed gently
by inversion at 37 1C for 2 h. The mixture was extracted two times
with TSE-saturated phenol and once with chloroform-isoamyl
alcohol (24:1). Nucleic acid was precipitated by adding sodium
acetate and ethanol and collected by centrifugation. The nucleic
acid was dissolved in 0.01 M Tris–HCl, pH 7.4, 0.1 M EDTA (10.1 TE)
and treated with 100 mg/ml of RNAse A and 8 u/ml of RNAse T1
for 30 min at 371. Nucleic acid was extracted with organic solvents
and collected by precipitation as described above, and suspended
in 10.1 TE for DNA sequencing.
HCMV genomic resequencing
DNA was quantiﬁed in a Qubit 2.0 Fluorometer (Life Technol-
ogies), and 0.01–0.09 mg of DNA in 0.05 ml of 10.1 TE was sheared to
an average fragment size of 200 bp in a Covaris adaptive focused
acoustics ultrasonicator (Covaris; 175 W peak incident power; 10%,
duty factor; 200 cycles per burst; 120 s total treatment time). After
conﬁrming the appropriate DNA fragment size distribution in a
2100 Bioanalyzer (Agilent Technologies), a DNA library was gen-
erated for each sample (total of four) using Illumina TruSeq
multiplex adapters (Illumina) with the Kapa Library Prep kit (Kapa
Biosystems). Quality-checked sequencing libraries were pooled
and sequenced by MiSeq Nano Kit (Illumina) to generate a total
of one million of 2150 sequencing reads (250,000 reads per
sample). 872 K/mm2 of clusters were detected and a total of 1.11
million passed ﬁlter reads among 1.22 million total reads were
obtained. The percentage of high quality reads (Q score greater
than 30) was 96.7 (data not shown).
The sample with the lowest read number distribution had
163,000 reads (14.66% of 1.11 million total reads), corresponding to
32.6X coverage of the 240 Kb viral genome after accounting for the
proportion of human genome contamination. Initial de novo
assembly was performed with the DNASTAR Lasergene Genomics
Suite (DNASTAR). Assembly was ﬁnished using the Pustell DNA
matrix feature (Pustell and Kafatos, 1984) of MacVector v12.5
(MacVector, Inc.) to align assembled sequences with MerlinBAC
and TRGFPBAC reference sequences.
The MerlinΔ84recTR-1, 2 and 3 viral DNA preparations con-
tained varying amounts of TR UL84 DNA (data not shown)
indicating that the samples also contained Merlin genomes whose
viability had been rescued by recombination with TR UL84 region
sequences. The repaired UL84 recombinant must have contami-
nated the Δ84recTR virus, most likely as an unrecognized compo-
nent of the contents of wells in the 12-well plates in the limiting
dilution experiment (see above). Preferential ampliﬁcation of the
UL84-containing variant during subsequent passage of the virus
stock, which was not plaque-puriﬁed, would be expected because
of its presumed growth advantage over the Δ84TRrec virus [this
work, (Spector and Yetming, 2010)]. The ampliﬁcation of UL84
DNA was conﬁrmed by PCR analysis of the DNA from the original
and passaged virus stocks (data not shown). The uncertainty in
interpretation introduced by the contaminating UL84-containing
virus was eliminated by the additional genetic analysis described
in the Results section.
Protein analysis
Protocols for immunoﬂuorescence and immunoblotting, includ-
ing the sources of antibodies, and for imaging of green ﬂuorescent
protein or its mCherry variant in live MRC5 cells growing and
infected on cover slips were described previously (Spector and
Yetming, 2010).
Growth curves
Growth curves were performed on infected cells growing in
multi-well tissue culture plates as described previously (Spector
and Yetming, 2010). Virus concentrations in harvested samples
were determined by plaque titration.
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